FCX
63
-2
OXY
40
3
DG
68
13
V
36
-4
GOOGL
53
-3
BAX
42
-5
HSY
37
2
ES
45
5
KHC
25
-4
IVZ
68
15
BBY
41
-9
FOXA
55
2
MLM
63
2
KR
40
6
CI
42
-3
LOW
58
9
LYB
13
-7
LLY
65
-3
AAL
50
-4
FLS
65
2
FCX
63
-2
OXY
40
3
DG
68
13
V
36
-4
GOOGL
53
-3
BAX
42
-5
HSY
37
2
ES
45
5
KHC
25
-4
IVZ
68
15
BBY
41
-9
FOXA
55
2
MLM
63
2
KR
40
6
CI
42
-3
LOW
58
9
LYB
13
-7
LLY
65
-3
AAL
50
-4
FLS
65
2
Financhill
Back

Candel Therapeutics, Inc. 10K Form

Sell
50

CADL
Candel Therapeutics, Inc.

Last Price:
$5.26
Seasonality Move:
8.7%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CADL News And Ratings

See the #1 stock for the next 7 days that we like better than CADL

CADL Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-10.4M
Price / Cash Flow: 0
Annual Sales: $1.46
Price / Book: 3.6

Profitability

EPS (TTM): -0.55940
Net Income (TTM): $-22.8M
Gross Margin: $-990K
Return on Equity: -38.43%
Return on Assets: -26.83%

Candel Therapeutics, Inc. Earnings Forecast

Key Candel Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 6 years have been positive in 1 years.

Candel Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CADL
Website: candeltx.com

Debt

Debt-to-Equity Ratio: 0.09
Current Ratio: 8.25
Quick Ratio: 7.96

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CADL Technical Analysis vs Fundamental Analysis

Sell
50
Candel Therapeutics, Inc. (CADL) is a Sell

Is Candel Therapeutics, Inc. a Buy or a Sell?